Dorzolamide Hydrochloride/Timolol Maleate/Brimonidine Tartrate

盐酸多佐胺/马来酸噻吗洛尔/酒石酸溴莫尼定

Report date: 2023/12/22 11:23:56

Base Information

Drug NameDorzolamide Hydrochloride/Timolol Maleate/Brimonidine Tartrate
Drug Alias Name盐酸多佐胺马来酸噻吗洛尔酒石酸溴莫尼定Brimonidine Tartrate/Dorzolamide Hydrochloride/Timolol MaleateDorzolamide Hydrochloride and Timolol Maleate and Brimonidine TartrateKrytantek OftenoPRO-122 +[6] 
ClassificationSmall molecules
Mechanisms of ActionCarbonic anhydrases inhibitorsAdrenergic receptors alpha-2 agonistsBeta adrenergic receptors antagonists
TargetsCarbonic anhydrasesBeta adrenergic receptorsAdrenergic receptors alpha-2
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucomaOcular Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date2007/09/01
Country/TerritoryMexicoColombia
CombinationsYes Dorzolamide HydrochlorideBrimonidine TartrateTimolol Maleate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Sophia Sa De Cv
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Sophia Sa De Cv
Inactive CompaniesN/A
Active IndicationsGlaucomaOcular Hypertension
Inactive IndicationsGlaucoma, Open-Angle

Other Information

ATC CodeS01E
Related LinksN/A